BCL11B (B-cell lymphoma/leukaemia 11B)

2004-07-01   Roderick A F MacLeod , Stefan Nagel 

DSMZ - Deutsche Sammlung von Mikroorganismen und Zellkulturen, Mascheroder Weg 1b 38124, Braunschweig, Germany

Identity

HGNC
LOCATION
14q32.2
IMAGE
Atlas Image
LOCUSID
ALIAS
ATL1,ATL1-alpha,ATL1-beta,ATL1-delta,ATL1-gamma,CTIP-2,CTIP2,IDDFSTA,IMD49,RIT1,ZNF856B,hRIT1-alpha
FUSION GENES

DNA/RNA

Atlas Image

Description

ORF comprises 4 exons, exon 3 being alternately spliced, while the 3 part of exon 4 is untranslated. Alternative splice variants due to presence (var.1) or absence (var.2) of exon 3.

Transcription

In a telomeric --> centromeric orientation.

Proteins

Atlas Image

Description

894 amino acids, 95.5 kDa; contains 6 krueppel-like Zn-finger domains and a proline-rich region

Expression

Normal expression in thymus and brain; malignant expression in T-cell neoplasia and Ewing-family tumors.

Localisation

Inner nuclear membrane; colocalization with heterochromatin protein (HP1) and histone deacetylase SIRT1 suggests role as transcriptional repressor.

Function

Poorly defined; transcriptional repressor; developmentally regulates thymic differentiation and survival; inhibits HIV-1 Tat transactivation and repression of viral replication.

Homology

BCL11A on chromosome 2p13.

Mutations

Somatic

Unrecorded in humans. Biallelic mutation/deletion in mouse thymic lymphomas induced by ionizing radiation.

Implicated in

Entity name
T-cell acute lymphoblastic leukemia (T-ALL) with t(5;14)(q35;q32) --> TLX3 - BCL11B
Disease
First detected as translocation partner of TLX3 (alias HOX11L2) in 15-20% pediatric cortical T-ALL with possible male bias; subsequently confirmed in adult T-ALL, albeit less frequently.
Prognosis
May be poor via strong cytogenetic assocation with TLX3 which reportedly confers adverse prognosis.
Cytogenetics
Additional known recurrent rearrangements reportedly absent from t(5;14) patients.
Oncogenesis
Distal regulatory elements drive ectopic expression of TLX3 in T-ALL and possibly other related NK-family Hox genes, viz. NKX2-5. Tumor suppressor role reported in mouse yet to be confirmed in man.

Breakpoints

Atlas Image
Atlas Image

Note

t(5;14) breakpoints are widely scattered over 1.2 Mbp downstream of BCL11B probably targeting distal enhancer(s) posited to lie in the "gene desert" separating BCL11b from VRK1. This region has been recently shown to carry multiple Dnase-I sensitive sites in T-cells which may represent a locus control region. The solitary AML breakpoint lies upstream of BCL11B and its significance has yet to be established.

Bibliography

Pubmed IDLast YearTitleAuthors

Other Information

Locus ID:

NCBI: 64919
MIM: 606558
HGNC: 13222
Ensembl: ENSG00000127152

Variants:

dbSNP: 64919
ClinVar: 64919
TCGA: ENSG00000127152
COSMIC: BCL11B

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000127152ENST00000345514Q9C0K0
ENSG00000127152ENST00000345514L8B567
ENSG00000127152ENST00000357195Q9C0K0
ENSG00000127152ENST00000357195L8B7P7
ENSG00000127152ENST00000443726D3YTK1

Expression (GTEx)

0
5
10
15
20
25

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
172454312007Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.165
160917502005BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.68
218786752011The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.65
129308292003Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression.53
195819322009p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.51
220683352012Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.34
238527302013CTIP2 is a negative regulator of P-TEFb.34
156687002005Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.33
185957222008Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.31
173080842007Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.28

Citation

Roderick A F MacLeod ; Stefan Nagel

BCL11B (B-cell lymphoma/leukaemia 11B)

Atlas Genet Cytogenet Oncol Haematol. 2004-07-01

Online version: http://atlasgeneticsoncology.org/gene/392/css/lib/css/card-gene.css